Unknown

Dataset Information

0

Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes.


ABSTRACT: Progressive damage of retinal ganglion cells (RGCs) is observed in early diabetic retinopathy. Intracellular Ca2+ overload mediated by Ca2+ influx through voltage-gated Ca2+ channels (VGCCs) is involved in neurodegeneration, whereas glucagon-like peptide-1 (GLP-1) provides neuroprotection. However, whether GLP-1 plays a neuroprotective role in diabetic retinas by modulating VGCCs remains unknown. We found that eye drops of exendin-4, a long-acting GLP-1 receptor (GLP-1R) agonist, prevented the increase of L-type Ca2+ current (ILCa) densities of RGCs induced by 4-week hyperglycemia and promoted RGC survival by suppressing L-type VGCC (L-VGCC) activity in streptozotocin-induced diabetic rats. Moreover, exendin-4-induced suppression of ILCa in RGCs may be mediated by a GLP-1R/Gs/cAMP-PKA/ryanodine/Ca2+/calmodulin/calcineurin/PP1 signaling pathway. Furthermore, exendin-4 functionally improved the light-evoked spiking ability of diabetic RGCs. These results suggest that GLP-1R activation enhances cAMP to PP1 signaling and that PP1 inactivates L-VGCCs by dephosphorylating them, thereby reducing Ca2+ influx, which could protect RGCs against excitotoxic Ca2+ overload.

SUBMITTER: Wang YC 

PROVIDER: S-EPMC10481356 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes.

Wang Yong-Chen YC   Wang Lu L   Shao Yu-Qi YQ   Weng Shi-Jun SJ   Yang Xiong-Li XL   Zhong Yong-Mei YM  

iScience 20230818 9


Progressive damage of retinal ganglion cells (RGCs) is observed in early diabetic retinopathy. Intracellular Ca<sup>2+</sup> overload mediated by Ca<sup>2+</sup> influx through voltage-gated Ca<sup>2+</sup> channels (VGCCs) is involved in neurodegeneration, whereas glucagon-like peptide-1 (GLP-1) provides neuroprotection. However, whether GLP-1 plays a neuroprotective role in diabetic retinas by modulating VGCCs remains unknown. We found that eye drops of exendin-4, a long-acting GLP-1 receptor  ...[more]

Similar Datasets

| S-EPMC10314105 | biostudies-literature
| S-EPMC3252838 | biostudies-other
| S-EPMC9151775 | biostudies-literature
| S-EPMC9679710 | biostudies-literature
| S-EPMC4826138 | biostudies-literature
| S-EPMC3854761 | biostudies-literature
| S-EPMC5480866 | biostudies-literature
| S-EPMC8626852 | biostudies-literature
| S-EPMC10749609 | biostudies-literature
| S-EPMC4669798 | biostudies-literature